Article PubMed
Arthritis Res Ther.  (2016)

Comparable long-term efficacy, as assessed by patient-reported outcomes, safety and pharmacokinetics, of CT-P13 and reference infliximab in patients with ankylosing spondylitis=> 54-week results from the randomized, parallel-group PLANETAS study.

Won Park, Dae Hyun Yoo; corresponding author Janusz Jaworski, Jan Brzezicki; Andriy Gnylorybov, Vladimir Kadinov; Irmgadt Goecke Sariego, Carlos Abud-Mendoza; William Jose Otero Escalante, Seong Wook Kang; Daina Andersone, Francisco Blanco